Efficacy and safety of amiodarone and metoprolol in the treatment of ventricular premature beats: a meta-analysis.
- Author:
Zhi-jun HUANG
1
;
Tao LI
;
Miao-quan YANG
;
Yu-ling WU
;
Ya-ling LI
Author Information
- Publication Type:Journal Article
- MeSH: Amiodarone; adverse effects; therapeutic use; Drug Therapy, Combination; Humans; Metoprolol; adverse effects; therapeutic use; Treatment Outcome; Ventricular Premature Complexes; drug therapy
- From: Journal of Southern Medical University 2010;30(11):2577-2580
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo evaluate the efficacy and safety of amiodarone and metoprolol in the treatment of ventricular premature beats.
METHODSControlled randomized clinical trials from 1999 through 2009 were retrieved in China HowNet, VIP Web, Pubmed home. Using Rev Man4.2 software provided by Cochrane Collaboration, Meta-analysis was conducted of 30 articles meeting the inclusion criteria involving a total of 1188 patients.
RESULTSMerged analysis of amiodarone and metoprolol in the treatment of premature ventricular merge showed a comprehensive test results of Z=1.25, P=0.21, OR=1.18, 95%CI: 0.91-1.54; funnel plot analysis suggested the possible presence of publication bias. The comprehensive test of the incidence of adverse reactions in relation to the two drugs resulted in an OR of 1.96 (95%CI: 1.39-2.77), and funnel plot analysis also indicated publication bias.
CONCLUSIONSThe total response rate of amiodarone does not seem to be superior to metoprolol in the treatment of premature ventricular contractions, and amiodarone is associated with higher incidence of adverse reactions.
